Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Aim. To compare the effectiveness of telmisartan and perindopril in the treatment of elderly patients with arterial hypertension (AH) and metabolic syndrome (MS) who have suffered ischemic stroke (IS).Material and methods. 92 elderly patients with AH and MS who underwent IS (mean 68±4 years) were ex...
Saved in:
Main Authors: | O. A. Osipova, A. N. Ilnitsky, E. V. Gosteva, S. G. Gorelik, L. V. Vasilyeva, N. I. Klyushnikov, N. I. Golovina, Yu. V. Tatarintseva, Yu. A. Lykov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2022-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01) -
Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects
by: V. Kubesh, et al.
Published: (2020-11-01) -
TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01) -
Treatment of hypertension in obese patients: focus on telmisartan
by: I. E. Deneka, et al.
Published: (2018-12-01) -
Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
by: A. O. Konradi, et al.
Published: (2025-02-01)